The gut microbiota, a diverse assemblage of microorganisms inhabiting the
gastrointestinal tract, profoundly influences human health and disease. Comprised of
bacterial taxa such as Bacteroidetes, Firmicutes, Actinobacteria, and Proteobacteria,
this intricate ecosystem engages in symbiotic interactions with the host, exerting
regulatory effects on various physiological processes. Prebiotics, indigestible dietary
fibers including inulin, oligosaccharides, and resistant starches, selectively nourish
beneficial gut bacteria, promoting their proliferation and metabolic activity. Through
fermentation, prebiotics yield short-chain fatty acids (SCFAs) such as acetate,
propionate, and butyrate, pivotal in supporting intestinal health and function.
Probiotics, live microorganisms administered in sufficient quantities, confer health
benefits through producing metabolites such as vitamins, enzymes, and SCFAs during
fermentation. These bioactive compounds contribute to immune modulation, nutrient
absorption, and the preservation of gut epithelial integrity. The profound importance of
gut microbiota extends beyond gastrointestinal health, impacting metabolic, immune,
and neurological functions. Dysbiosis, characterized by perturbations in microbial
composition, has been implicated in a spectrum of disorders, including inflammatory
bowel diseases, obesity, and neurodegenerative conditions. Understanding the diversity
of gut microbiota and their metabolites is pivotal for devising targeted interventions to
modulate microbial communities and optimize health outcomes. Metagenomic
investigations have unveiled distinct microbial signatures associated with dietary
habits, diseases, and physiological states, underscoring the dynamic nature of the gut
microbiome and its potential as a therapeutic avenue.
Keywords: Dietary metabolites, Gut-brain axis, Gut microbiome, Immune modulation, Probiotics, Prebiotics, Short-Chain Fatty Acids (SCFAs), Vitamin metabolites.
